Followers | 8 |
Posts | 278 |
Boards Moderated | 0 |
Alias Born | 05/07/2012 |
Tuesday, October 30, 2018 11:34:34 AM
I never thought seriously about buyouts until recently. Reason being is there is a huge task ahead to get even close to making this a household name. I am behind the tech 1,000% but I find it hard to believe if/when BB or Bayer come in to business with BIEL that they won't try and buy the whole thing. It would not be much capital at all for them. $500M seems reasonable but I think true street value is higher than that, but who else will think that? Will hedge funds think that? Will AW still even own BIEL if they make it to the DAX or NYSE?
I still have a lot of patience left for BIEL, but I also started getting in to BIEL when I was in my mid-20's. I feel for the investors at or in retirement waiting for this to be realized. I have a FDA approval sell order set to above a penny but for only about 4% of the shares I am holding.
I was very happy to see them hire a Dir of Regulatory Affairs to be located in Frederick. AW wouldn't do that unless he knew he needed the bandwidth and help. In the past, AW navigated all of that stuff. KN's job is to sell sell sell and SK's job is to promote the tech, develop new studies and handle FDA filings etc.
I am not an expert on the share structure but that has always been a looming question on what will happen to us. If I cash out up 400% on the year after approval I will be disappointed. I think true long value could be as high as $3-5 BUSD. I keep reading balance sheets of mid-cap Healthcare companies with $3B market value and no profitability. But they also have hundreds of employees. BIEL has around 7 (that are not in production filling boxes).
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM